New Zealand’s Drug Funder Pulls Alternative Brand Allowance Proposal Following Industry Comments
This article was originally published in PharmAsia News
Executive Summary
New Zealand's Pharmaceutical Management Agency said it will put the brakes on its Alternative Brand Allowance proposal, but it will keep working to find a more practical mechanism to provide flexibility with its sole-supply tender